Published on September 22, 2009 at 7:06 AM
Research and Markets (http://www.researchandmarkets.com/research/f2ffa1/current_and_emergi) has announced the addition of the "Current and Emerging Cancer Diagnostic Tests: Emerging Assays and Companies Developing New Technologies and Products" report to their offering.
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.
http://www.researchandmarkets.com
25fd2f9e-7c7f-4c37-a5f5-204032e774d9|0|.0
Posted in: Device / Technology News | Medical Condition News
Tags: Calcitonin, Cancer, Cell, Estrogen, Gonadotropin, Hormone, Insulin, Pap Smear, Progesterone, Prostate-Specific Antigen, Squamous Cell Carcinoma